Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    Welcome !
    My account
    Logout

Arena Pharmaceuticals Inc (ARNA) Stock Forecast 2025 - AI Price Prediction & Analysis

Arena Pharmaceuticals Inc (ARNA) AI Stock Price Forecast & Investment Analysis

Arena Pharmaceuticals Inc Stock Price Chart and Technical Analysis

Loading Arena Pharmaceuticals Inc interactive price chart and technical analysis...

Arena Pharmaceuticals Inc (ARNA) - Comprehensive Stock Analysis & Investment Research

Deep dive into Arena Pharmaceuticals Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Arena Pharmaceuticals Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Arena Pharmaceuticals Inc: Arena Pharmaceuticals Inc operates in the Manufacturing sector, establishing it as a mid-cap growth opportunity.

Arena Pharmaceuticals Inc (Stock Symbol: ARNA) is a leading company in the Manufacturing sector , specifically operating within the Pharmaceutical Preparation Manufacturing industry.

The organization employs approximately 363 professionals worldwide and operates under the strategic leadership of CEO Amit Munshi.

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Arena Pharmaceuticals Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Arena Pharmaceuticals Inc:

Market Capitalization: $5733 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -70.3% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Arena Pharmaceuticals Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Arena Pharmaceuticals Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Arena Pharmaceuticals Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Arena Pharmaceuticals Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Arena Pharmaceuticals Inc: Market positioning analysis based on available financial and operational metrics.

Arena Pharmaceuticals Inc strategically competes in the highly dynamic Pharmaceutical Preparation Manufacturing marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company maintains a healthy 87.6% gross margin, indicating strong pricing power and operational efficiency.

Arena Pharmaceuticals Inc (ARNA) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Arena Pharmaceuticals Inc stock analysis.

Loading Arena Pharmaceuticals Inc comprehensive fundamental analysis and insider trading data...

Deep dive into Arena Pharmaceuticals Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Arena Pharmaceuticals Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Arena Pharmaceuticals Inc: With a P/E ratio of -9.27, the market sees the stock as potentially undervalued.

P/E Ratio -9.27x
P/B Ratio 8.61x
Market Cap $5733M
EPS $-10.14
Book Value/Share $10.92
FCF/Share $-5.85
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Arena Pharmaceuticals Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Arena Pharmaceuticals Inc: An ROE of -70.3% indicates room for improvement in shareholder value creation.

ROE -70.3%
ROA -62.4%
ROIC -66.7%
Gross Margin 87.6%
Operating Margin 59.9%
Net Margin 49.3%
EBT Margin 63.0%
Tax Rate 21.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Arena Pharmaceuticals Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Arena Pharmaceuticals Inc: A current ratio of 8.59 indicates strong liquidity.

Current Ratio 8.59x
Quick Ratio 8.30x
D/E Ratio 0.05x
Financial Leverage 1.17x
Interest Coverage -147.2x
Working Capital $1081M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Arena Pharmaceuticals Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Arena Pharmaceuticals Inc: Free cash flow of $-523M indicates cash challenges that need attention.

Operating Cash Flow $-452M
Free Cash Flow $-523M
Capital Spending $-71M
FCF/Sales 69.9%
CapEx/Sales 982.5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Arena Pharmaceuticals Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Arena Pharmaceuticals Inc: An asset turnover of 0.87x suggests room for improvement in asset utilization.

Asset Turnover 0.87x
Receivables Turnover 239.3x
Inventory Turnover 1.9x
Fixed Assets Turnover 0.0x
Days Sales Outstanding 2 days
Days Inventory 193 days
Payables Period 96 days
Cash Conversion Cycle 134 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Arena Pharmaceuticals Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Arena Pharmaceuticals Inc:

Income Statement ($ Millions)
Operating Income $-554M
Net Income $-616M
R&D Expense $29M
SG&A Expense $10M
Cost of Goods Sold $12M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 73%
Cash & Short-term Investments 70%
Total Liabilities 14%
Short-term Debt 8%
Accounts Receivable 0%
Inventory 4%
Dividend & Shareholder Information
Shares Outstanding 61M

Latest Arena Pharmaceuticals Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Arena Pharmaceuticals Inc (ARNA) stock price and investment outlook.

, source: Insider Monkey

Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case they’re material to our investing thesis. So what: The ...

, source: San Antonio Express-News

Arena Pharmaceuticals ended down 3.8% Friday after announcing earnings on Thursday night that included a rather paltry $2.3 million in revenue from sales of its obesity drug Belviq. The sales don't ...

Arena Pharmaceuticals Inc Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of Arena Pharmaceuticals Inc against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Arena Pharmaceuticals Inc Stock Forecast

How accurate are Arena Pharmaceuticals Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for ARNA predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Arena Pharmaceuticals Inc stock price forecasts?

Our analysis considers Arena Pharmaceuticals Inc's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Arena Pharmaceuticals Inc a good investment in 2025?

Based on our AI analysis, Arena Pharmaceuticals Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Arena Pharmaceuticals Inc forecasts updated?

Arena Pharmaceuticals Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Arena Pharmaceuticals Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Arena Pharmaceuticals Inc stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...